The Innovative Medicines Initiative (IMI) is a European initiative to improve the competitive situation of the European Union in the field of pharmaceutical research. The IMI is a joint initiative (public-private partnership) of the DG Research of the European Commission representing the European Communities and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
funded by
European Commission, European Federation of Pharmaceutical Industries and Associations
project budget funding ($)
1.0E9
project budget total ($)
2.0E9
project keyword
Drug discovery Drug development
project objective
Re-invigorate the European bio-pharmaceutical sector and to make Europe more attractive for private research and development (R&D) investment in this sector
project type
Joint Technology Initiative (JTI)
title
Joint Technology Initiative on Innovative Medicines